Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C

NCT01500772 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Alisporivir
DRUG: Peginterferon alfa-2a
DRUG: Ribavirin

Sponsor

Debiopharm International SA